MedTrace Logo

Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin

NCT05767203 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2023-03-14

No results posted yet for this study

Summary

Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.

Conditions

  • Down Syndrome
  • Intellectual Disability

Interventions

OTHER

Biological samplings

Blood and/or skin samples

Sponsors & Collaborators

  • Institut Jerome Lejeune

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2032-09-01
Completion
2032-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767203 on ClinicalTrials.gov